Paper Details
- Home
- Paper Details
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits.
Author: ChenXu, CongXin, DefensorErwin, EllerbyLisa, GanLi, GestwickiJason, GibsonBradford W, JohnsonJeffrey, KroganNevan, LiYaqiao, MasliahEliezer, MinSang-Won, MinamiS Sakura, MokSue Ann, SchillingBirgit, ShamlooMehrdad, ShirakawaKotaro, SohnPeter Dongmin, TracyTara E, VerdinEric, WangChao, ZhouYungui
Original Abstract of the Article :
Tauopathies, including frontotemporal dementia (FTD) and Alzheimer's disease (AD), are neurodegenerative diseases in which tau fibrils accumulate. Recent evidence supports soluble tau species as the major toxic species. How soluble tau accumulates and causes neurodegeneration remains unclear. Here w...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/26390242
データ提供:米国国立医学図書館(NLM)
Unraveling the Mystery of Tau Acetylation in Neurodegenerative Diseases
The study dives deep into the intricate world of neurodegenerative diseases, specifically tauopathies, like Alzheimer's disease and frontotemporal dementia. These conditions involve the accumulation of tau protein, which forms toxic fibrils in the brain. While the role of soluble tau species in neurodegeneration is gaining recognition, the exact mechanisms behind their accumulation and toxicity are still under investigation. This research sheds light on a critical aspect of this complex process by examining the role of tau acetylation, specifically at Lys174 (K174).Tau Acetylation: A Key Player in Neurodegeneration
Researchers discovered that tau acetylation at K174 is an early event in Alzheimer's disease and plays a crucial role in the stability and toxicity of tau protein. The study demonstrates that altering tau acetylation affects its turnover rate and consequently influences cognitive function. The results show that mimicking acetylation at K174 slows down tau turnover and leads to cognitive deficits in mice. Conversely, inhibiting tau acetylation by using drugs like salsalate and salicylate enhances tau turnover and reduces tau levels, potentially mitigating cognitive decline. Furthermore, the study found that salsalate can effectively reduce tau-induced memory deficits and prevent hippocampal atrophy in a mouse model of frontotemporal dementia. This suggests that targeting tau acetylation could be a promising therapeutic strategy for treating neurodegenerative diseases.A Glimpse into the Future of Tauopathy Treatment
These findings hold significant implications for treating neurodegenerative diseases. By understanding the crucial role of tau acetylation, researchers can develop new therapeutic strategies aimed at modulating tau acetylation to prevent or delay disease progression. Imagine a vast desert landscape, where tau acetylation is a hidden oasis, providing a potential source of relief for those suffering from these debilitating conditions.Dr.Camel's Conclusion
This research offers valuable insight into the complex mechanisms underlying neurodegeneration and presents a promising avenue for therapeutic intervention. By exploring the role of tau acetylation, researchers are paving the way for innovative approaches to combat these devastating diseases.Date :
- Date Completed 2016-01-19
- Date Revised 2022-03-31
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.